Glen Eagle Advisors’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4
| Closed | -$4 | – | 1221 |
|
|
2024
Q1 | $4 | Hold |
4
| – | – | ﹤0.01% | 1107 |
|
|
2023
Q4 | $8 | Hold |
4
| – | – | ﹤0.01% | 1043 |
|
|
2023
Q3 | $15 | Buy |
4
+1
| +33% | +$4 | ﹤0.01% | 1020 |
|
|
2023
Q2 | $16 | Hold |
3
| – | – | ﹤0.01% | 1062 |
|
|
2023
Q1 | $16 | Hold |
3
| – | – | ﹤0.01% | 1074 |
|
|
2022
Q4 | $15 | Hold |
3
| – | – | ﹤0.01% | 1148 |
|
|
2022
Q3 | $61 | Hold |
3
| – | – | ﹤0.01% | 1074 |
|
|
2022
Q2 | $168 | Hold |
3
| – | – | ﹤0.01% | 979 |
|
|
2022
Q1 | $470 | Hold |
3
| – | – | ﹤0.01% | 906 |
|
|
2021
Q4 | $570 | Hold |
3
| – | – | ﹤0.01% | 886 |
|
|
2021
Q3 | $1.66K | Hold |
3
| – | – | ﹤0.01% | 944 |
|
|
2021
Q2 | $1.67K | Hold |
3
| – | – | ﹤0.01% | 937 |
|
|
2021
Q1 | $1.69K | Hold |
3
| – | – | ﹤0.01% | 899 |
|
|
2020
Q4 | $1.59K | Hold |
3
| – | – | ﹤0.01% | 870 |
|
|
2020
Q3 | $957 | Hold |
3
| – | – | ﹤0.01% | 851 |
|
|
2020
Q2 | $637 | Hold |
3
| – | – | ﹤0.01% | 839 |
|
|
2020
Q1 | $415 | Hold |
3
| – | – | ﹤0.01% | 792 |
|
|
2019
Q4 | $583 | Hold |
3
| – | – | ﹤0.01% | 858 |
|
|
2019
Q3 | $501 | Hold |
3
| – | – | ﹤0.01% | 780 |
|
|
2019
Q2 | $388 | Hold |
3
| – | – | ﹤0.01% | 763 |
|
|
2019
Q1 | $562 | Hold |
3
| – | – | ﹤0.01% | 719 |
|
|
2018
Q4 | $395 | Hold |
3
| – | – | ﹤0.01% | 706 |
|
|
2018
Q3 | $508 | Hold |
3
| – | – | ﹤0.01% | 694 |
|
|
2018
Q2 | $2.2K | Hold |
3
| – | – | ﹤0.01% | 604 |
|
|
2018
Q1 | $3.4K | Hold |
3
| – | – | ﹤0.01% | 564 |
|
|
2017
Q4 | $4.07K | Buy |
+3
| New | +$1.41K | ﹤0.01% | 532 |
|
Other funds holding AMPE
Glen Eagle Advisors's AMPE Position: Q2 2024 in Review
Glen Eagle Advisors sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2024, closing a stake of 4 shares — an estimated $4 sold.
Glen Eagle Advisors first reported a position in AMPE in Q4 2017 and held it in 26 quarters. The position peaked at $4.07K in Q4 2017. 6 funds tracked by Wall St. Rank hold AMPE as of Q2 2024.
- Glen Eagle Advisors reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2024 after selling out during the quarter.
- Glen Eagle Advisors sold 4 Ampio Pharmaceuticals Inc. shares in Q2 2024, an estimated $4.
- Glen Eagle Advisors first reported a position in Ampio Pharmaceuticals Inc. in Q4 2017 and held it in 26 quarters.
- Glen Eagle Advisors's Ampio Pharmaceuticals Inc. position peaked at $4.07K in Q4 2017.
- 6 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2024.
Based on Glen Eagle Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.